Drug Discovery and Therapeutics

February 06-08, 2023, 9:00AM

NYUAD Campus

Past Event

By Invitation

Interested scholars please contact nyuad.programs@nyu.edu

Recent advances in genomics, proteomics, and computational biology are allowing scientists to define coding genes and disease-causing mutations more precisely. Conference participants describe their cutting-edge research and approaches to identifying and characterizing drug targets, and how drugs are being developed for such targets. The conference brings to NYUAD international and UAE renowned scientists to present their work on finding new targets and drugs for human diseases.

Speakers

prSpeaker Name	Talk Title
Pascal Falter-Braun, Ludwig-Maximilians-University (LMU) München (Keynote - Day 1)	Interactome networks to understand genetic and infectious diseases and facilitate drug discovery
Julien Olivet, KU Leuven University	Targeting protein-protein interactions in HDAC complexes
Diana El Assal, NYUAD	The reconstruction and application of a green-monkey metabolic model for the identification of drug targets for COVID-19 infections
Christoph Gorgulla, Harvard University	VirtualFlow - A Computational Drug Discovery Platform for Ultra-Large Virtual Screenings
Ali Trabolsi, NYUAD	Smart Porous Materials For Drug Delivery
Peter Shepherd, Univesity of Auckland, New Zealand	Developing precision medicine strategies for metabolic disease targeting population specific genetic variants
Yasmine Mandour, University of Hertfordshire, Egypt	Novel Allosteric Chemokine Receptors’ Inhibitors for Colorectal Cancer Treatment
Rachid Sougrat, KAUST, K.S.A.	Cryo-EM: A “tour de force” becoming a routine application.
Sun-Shin Cha, Ewha Womans University, Seoul, Korea	Nucleotide-based approach for the development of b-lactamase inhibitors
Saif Alqassim, Mohammed Bin Rashid University Of Medicine and Health Sciences	Mechanism of actin assembly by Rickettsia Sca2: A tail of molecular mimicry
Lin-Woo Kang, Kunkuk University, Korea	Insights into structure and activity relationships of β-lactams and β-lactamases
Matthew Chang, National University of Singapore (Keynote - Day 2)	Reprogramming microbes to rewire host-microbiome interactions
Lucia Gemma Delogu, University of Padua	2D materials platforms immune interactions in the human health and the environment
Hassan Shabir, Khalifa University	3D tissue engineering: An emerging alternative to lab animals
Marcella Gomez, University of California Santa Cruz	Bioelectronics and machine learning to close the loop in biocontrol
Bushra Dohai, Ludwig-Maximilians-University (LMU) München	NiTRO, an algorithm for predicting drug repositioning, and its application on cells infected with coronaviruses
Mauro Giacca, King's College London, UK	RNA therapeutics for cardiac repair and regeneration
Martin Lohse, ISAR Bioscience, Munich, Germany	Delivering RNAs into cells for therapeutic purposes
Martin Hallberg, Karolinska Institute, Stockholm, Sweden	Cryo-EM and Nanobody Design for Rapid Pandemic Response
Serge Muyldermans, VUB, Belgium	Importance of Dromedaries in Generating Nanobodies
Sunil Kumar, University of Denver	Multidimensional synthetic protein mimetic approaches to modulate pathological protein-protein interactions
Melissa Birol, Max Delbrück Center for Molecular Medicine in the Helmholtz-Association	Tracing disease onset and progression through different lenses
Rihab Nasr, American University of Beirut	Optimizing therapies of chronic myeloid leukemia: One step closer to cure?
Khalid Salaita, Emory University	Smart nucleic acid drugs
Mohammed Akli Ayoub, Khalifa University	Dissecting the molecular mechanisms of the antidiabetic properties of camel milk